News

Lung Cancer Advocate Benay Taub Joins LCRF Board Efforts

Lung Cancer Advocate Benay Taub Joins LCRF Board Efforts

Benay Taub Joins the Lung Cancer Research Foundation Board

The Lung Cancer Research Foundation (LCRF) is excited to announce that Benay Taub has joined its Board of Directors. An advocate for lung cancer research, Benay's personal experience fuels her dedication to enhancing research initiatives.

Commitment to Lung Cancer Awareness

Having been diagnosed with Stage IV lung cancer, Benay found herself facing a daunting journey without any known risk factors for the disease. This surprising diagnosis ignited a passion within her to raise awareness and promote understanding about lung cancer. Benay is dedicated to advocating for increased funding to support innovative research that can lead to significant advancements in treatment options.

Background and Experience

Benay earned her undergraduate degree from the prestigious University of Pennsylvania and subsequently obtained her law degree from Brooklyn Law School. In New York, she serves as a Mediator and has been actively engaged with various charitable organizations, contributing to numerous Boards of Directors.

In addition to her legal background, Benay has pursued her culinary passions by earning certificates from the International Culinary Center and the New York Bartending School. She finds joy in striking a balance between her professional and personal life, where family plays a central role.

Benay and her husband, Steven, celebrate their life together as proud parents to four children, who inspire her every day.

Recent Contributions and Goals

Recently, Benay was the highlighted patient speaker at the LCRF Evening of Innovation gala. Her openness about her journey not only resonates with others facing similar situations but also fosters a deeper connection to the cause. The Taub family has made a significant impact by funding the "2025 LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung Cancers," which will be presented in early 2026.

Benay Taub's Vision for the Future

Expressing her motivations, Benay stated, "It's meaningful for me to be joining LCRF as a board member. Lung cancer research, which has been historically underfunded, is the reason that people like me have hope for the future." Her focus will not only be on advocating for impactful research but also on working collaboratively with fellow board members to drive the foundation's strategic goals, which aim to double its investment in research.

Colleen Conner Zeigler, chair of LCRF's Board, expressed confidence in Benay’s potential contributions, gracing the organization with her recent insights. She noted that having Benay's perspective as someone who has been newly diagnosed allows for a nuanced approach as they embark on a significant planning phase for future funding.

Aubrey Rhodes, LCRF's Executive Director, echoed this sentiment, emphasizing the importance of how lived experiences connect with ongoing research advances. He believes Benay's unique view will contribute meaningfully as LCRF strives to bolster research and ultimately improve outcomes for those living with lung cancer.

About the Lung Cancer Research Foundation

The Lung Cancer Research Foundation (LCRF) stands at the forefront as a nonprofit organization wholly dedicated to funding innovative, high-reward research aimed at improving survival outcomes and the quality of life for those diagnosed with lung cancer. With a mission centered on enhancing lung cancer outcomes, LCRF has remarkably funded 431 research grants, totaling nearly $49 million—an unprecedented collective effort by any nonprofit in lung cancer research funding.

To learn more about LCRF and its influential work, please visit the organization's official website for information on volunteer opportunities, funded research, and their comprehensive grants program.

Frequently Asked Questions

What motivated Benay Taub to join LCRF's Board of Directors?

Benay Taub's own experience with lung cancer inspires her to advocate for increased funding and research to foster hope for others impacted by the disease.

What contributions has Benay Taub made to lung cancer research initiatives?

She has funded a significant research award focused on advancing therapies for EGFR mutated lung cancers and has been active in public speaking to raise awareness.

How has LCRF impacted lung cancer research?

LCRF campaigns for the funding of innovative research projects aimed at improving survival and quality of life for lung cancer patients.

What is Benay Taub's professional background?

Benay Taub holds a law degree and has experience as a Mediator, along with various certifications in culinary arts, reflecting her diverse interests and commitment to community service.

What is LCRF's mission?

The Lung Cancer Research Foundation focuses on funding research that can drastically improve prevention, diagnosis, treatment, and potential cure for lung cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 69

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 80

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 18

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 118

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading

Top 5 Most Recently Viewed Articles

ArisGlobal's Commitment to Ethical AI Enhances Patient Safety

Updated Category News Views 108

ArisGlobal's Commitment to Ethical AI and Patient Safety The EU AI Pact is a significant step for organizations preparing for the EU AI Act, the groundbreaking legislation that regulates artificial intelligence globally. ArisGlobal, a pioneering technology firm in life sciences, recently signed the EU AI Pact, emphasizing its dedication to responsible AI practices and its...

Continue Reading
Important Update for PubMatic, Inc. Investors on Class Action

Updated Category News Views 110

Important Update for PubMatic, Inc. Investors The Gross Law Firm has issued an important notification to shareholders of PubMatic, Inc. (NASDAQ: PUBM) regarding a significant class action lawsuit. This might be crucial for investors who acquired shares during the specified class period. Encouragement to Shareholders Investors who purchased PUBM shares during the specified...

Continue Reading
Key Insights on De La Rue plc's Recent Trading Activities

Updated Category News Views 127

Overview of Trading Disclosures for De La Rue plc The latest report highlights important trading actions relating to De La Rue plc, showcasing the dealings by the exempt principal trader, Investec Bank plc, within a client-serving capacity. Under the Takeover Code, it's vital to transparently share relevant trading information that affects the stakeholders involved. Key...

Continue Reading
Investors Encouraged to Join Indivior PLC Class Action Lawsuit

Updated Category News Views 39

Investors Invited to Participate in Indivior PLC Class Action Lawsuit The Law Offices of Frank R. Cruz are actively seeking investors who have experienced substantial losses due to alleged securities fraud related to Indivior PLC (INDV). This presents a vital opportunity for shareholders to come forward as potential lead plaintiffs in this class action lawsuit. The case...

Continue Reading
ProCap Financial Emerges Following Strategic Business Combination

Updated Category News Views 242

ProCap Financial Commences Trading on Nasdaq In an exciting development within the financial sector, ProCap Financial is poised to start trading on the Nasdaq Global Market on a forthcoming date under the ticker symbol "BRR." This marks a significant milestone not only for ProCap BTC, LLC but also for the entire financial community that seeks innovative solutions in...

Continue Reading